Skip to content
Recall Observatory FDA recall evidence

Drug product

Dacarbazine, Injection, USP, 200mg, vials packaged in individual cartons, Rx only, Manufactured by Hospira Australia 1 Lexia Place, Mulgrave, Victoria Australia 3170. NDC 61703-327-22.

D-0313-2015

November 25, 2014

Class III

Product summary

Firm
Hospira Inc.
Event
Event 69900
Status
Terminated
Classification
Class III
Quantity
3,306 vials
Official record key
drug-enforcement:D-0313-2015

Official wording

Reason: Discoloration: Reconstituted solution may appear pink instead of colorless to pale yellow when stored per the labeled conditions.

Code information: Lot #: B032223AA; Exp: July 2016

Distribution pattern: Nationwide

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Discoloration: Reconstituted solution may appear pink instead of colorless to pale yellow when stored per the labeled conditions.